نتائج البحث - "Simone M. Goldinger"

وصف الملف: application/pdf; 700_Mangana_J._et_al._Multicenter,_real-life_experience_with_checkpoint_inhibitors_and_targeted_therapy_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bbb70f561a7092d8ff26c9a75ab8148Test
https://serval.unil.ch/notice/serval:BIB_15F2678EE65FTest

44

Interstitial granulomatous dermatitis during talimogen laherparepvec treatment

المؤلفون: Anna L. Frauchiger, Marie-Charlotte Brüggen, Simone M. Goldinger, Reinhard Dummer

المساهمون: University of Zurich, Dummer, Reinhard

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Interstitial granulomatous dermatitis, business.industry, 10177 Dermatology Clinic, 610 Medicine & health, Dermatology, medicine.disease, 2708 Dermatology, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Dermatology clinic, medicine, 2730 Oncology, 1306 Cancer Research, business

وصف الملف: 699_Frauchiger_A._et_al._Interstitial_granulomatous_dermatitis_during_talimogen_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02c2d4da3cc5ec158b3abc983bdba35Test
https://www.zora.uzh.ch/id/eprint/138317Test/

45

Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor

المؤلفون: Nadja Galliker, Carla Murer, Jivko Kamarashev, Simone M. Goldinger, Reinhard Dummer

المساهمون: University of Zurich, Goldinger, Simone M

المصدر: European Journal of Dermatology. 25:177-180

وصف الملف: 613_Galliker N et al._Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma_ Eur J Derm.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b485b9c369833945b22726d5950b35ffTest
https://doi.org/10.1684/ejd.2014.2512Test

46

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

المؤلفون: Elise A. Olsen, J. Scarisbrick, Nina Eggmann, Sima Rozati, Youn H. Kim, K. Hutchinson, Simone M. Goldinger, E. Giuliano, M. Duvic, Larisa J. Geskin, Timothy M Illidge, Reinhard Dummer, J. Elder

المساهمون: University of Zurich, Dummer, R

المصدر: Annals of Oncology. 25:1807-1812

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Skin Neoplasms, 2720 Hematology, Population, Peripheral edema, Phases of clinical research, Antineoplastic Agents, Apoptosis, 610 Medicine & health, Pyrimidinones, Gastroenterology, Forodesine, chemistry.chemical_compound, Mycosis Fungoides, Internal medicine, Humans, Sezary Syndrome, Medicine, Treatment Failure, education, Adverse effect, Aged, Aged, 80 and over, education.field_of_study, Mycosis fungoides, Performance status, business.industry, 10177 Dermatology Clinic, Purine Nucleosides, Hematology, Middle Aged, medicine.disease, Purine-Nucleoside Phosphorylase, Oncology, Tolerability, chemistry, Female, 2730 Oncology, medicine.symptom, business

وصف الملف: PIIS0923753419351099.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694ba0d9b4e9882f722d3661155f0c5dTest
https://doi.org/10.1093/annonc/mdu231Test

47

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

المؤلفون: Barbara Grimes, Adil Daud, Alain Algazi, Simone M. Goldinger, Katy K. Tsai, Adi Nosrati, Thi Dan Linh Nguyen-Kim, Omid Hamid, Kimberly Loo, Reinhard Dummer, Mitchell P. Levesque, Paul C. Tumeh

المساهمون: University of Zurich, Daud, Adil

المصدر: British journal of cancer, vol 116, iss 9
British Journal of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, advanced melanoma, Cancer Research, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Monoclonal, 1306 Cancer Research, Melanoma, Humanized, Cancer, screening and diagnosis, Univariate analysis, prediction scale, 10042 Clinic for Diagnostic and Interventional Radiology, Age Factors, 10177 Dermatology Clinic, Antibodies, Monoclonal, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Detection, 030220 oncology & carcinogenesis, Public Health and Health Services, 2730 Oncology, Female, immunotherapy, pembrolizumab, Nivolumab, 4.2 Evaluation of markers and technologies, medicine.drug, Cohort study, medicine.medical_specialty, Oncology and Carcinogenesis, 610 Medicine & health, Ipilimumab, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Neoplasm Staging, Aged, nivolumab, Neoplastic, L-Lactate Dehydrogenase, business.industry, Stepwise regression, medicine.disease, Clinical trial, 030104 developmental biology, Gene Expression Regulation, Clinical Study, business

وصف الملف: application/pdf; 690_Nosrati_A._et_al_Evaluation_of_clinicopathological_factors_in_PD-1_Br_J_Cancer_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d683abcf1a5f1faf44bf15c07b9b302Test
https://escholarship.org/uc/item/8w50t9twTest

48

Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab

المؤلفون: Michael Stürzl, Andreas Konrad, Roland S. Croner, Michael C. Kirchberger, Simone M. Goldinger, Gerhard Schuler, Christian Hafner, Benjamin Weide, Lukas Krähenbühl, Dirk Schadendorf, Lucie Heinzerling, Michael Erdmann, Katharina C. Kähler, Reinhard Dummer, C. Brüggemann, Waltraud Leisgang, Franklin Kiesewetter

المساهمون: University of Zurich, Heinzerling, L

المصدر: Journal of cancer research and clinical oncology. 143(10)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Pathology, Skin Neoplasms, Dacarbazine, Medizin, Gene Expression, 610 Medicine & health, Ipilimumab, Pembrolizumab, Real-Time Polymerase Chain Reaction, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Internal medicine, medicine, Humans, 1306 Cancer Research, RNA, Messenger, Melanoma, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Predictive marker, business.industry, 10177 Dermatology Clinic, General Medicine, Middle Aged, medicine.disease, Immunohistochemistry, 030104 developmental biology, 030220 oncology & carcinogenesis, Case-Control Studies, Biomarker (medicine), 2730 Oncology, Female, Skin cancer, business, medicine.drug

وصف الملف: 695_Bruggemann_C._et_al._Predictive_value_of_PD-L1_based_on_mRNA_level_in_the_treatment_J_Cancer_Res_Clin_Oncol_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eed038541f1098129c473bba70f7f55Test
https://pubmed.ncbi.nlm.nih.gov/28616701Test

49

Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma

المؤلفون: Valerie C Amann, J. Mangana, D. Hoffmann, Simone M. Goldinger, Reinhard Dummer

المساهمون: University of Zurich, Goldinger, S M

المصدر: Journal of the European Academy of Dermatology and Venereology : JEADV. 31(10)

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, Standard of care, endocrine system diseases, medicine.medical_treatment, 610 Medicine & health, Antineoplastic Agents, Dermatology, Targeted therapy, 2708 Dermatology, 03 medical and health sciences, 0302 clinical medicine, Medicine, Humans, Stage IIIC, 030212 general & internal medicine, Neoplasm Metastasis, neoplasms, Melanoma, Protein Kinase Inhibitors, business.industry, Kinase, MEK inhibitor, 10177 Dermatology Clinic, Treatment options, 2725 Infectious Diseases, Immunotherapy, Middle Aged, medicine.disease, MAP Kinase Kinase Kinases, digestive system diseases, Infectious Diseases, 030220 oncology & carcinogenesis, Cancer research, Quality of Life, Female, business

وصف الملف: 718_Amann_V._et_al._Successful_retreatment_with_combined_BRAF_MEK_inhibition_JEADV_2017.pdf - application/pdf; 23646-65027-1-PB.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c212ea697b903621212dcdc08f355ceTest
https://pubmed.ncbi.nlm.nih.gov/28401596Test

50

A review of serious adverse effects under treatment with checkpoint inhibitors

المؤلفون: Lucie Heinzerling, Simone M. Goldinger

المصدر: Current opinion in oncology. 29(2)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, business.industry, Immune checkpoint inhibitors, MEDLINE, Antibodies, Monoclonal, Bioinformatics, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Neoplasms, Blocking antibody, Medicine, Humans, Adverse effect, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba066cf3be9e1af63289f62628cd96aTest
https://pubmed.ncbi.nlm.nih.gov/28059853Test

تنقيح النتائج